Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.

× No keyword cloud information.

10 in total

1. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.

Authors: Benjamin P Howden; Peter B Ward; Patrick G P Charles; Tony M Korman; Andrew Fuller; Philipp du Cros; Elizabeth A Grabsch; Sally A Roberts; Jenny Robson; Kerry Read; Narin Bak; James Hurley; Paul D R Johnson; Arthur J Morris; Barrie C Mayall; M Lindsay Grayson
Journal: Clin Infect Dis Date: 2004-01-29 Impact factor: 9.079

2. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors: Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal: Clin Infect Dis Date: 2009-07-01 Impact factor: 9.079

Review 3. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors: Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal: Am J Health Syst Pharm Date: 2009-01-01 Impact factor: 2.637

4. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.

Authors: Robert E Ariano; Adrian Fine; Daniel S Sitar; Stacey Rexrode; Sheryl A Zelenitsky
Journal: Am J Kidney Dis Date: 2005-10 Impact factor: 8.860

5. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.

Authors: R H Barth; N DeVincenzo
Journal: Kidney Int Date: 1996-09 Impact factor: 10.612

6. Pharmacokinetics of vancomycin in patients with various degrees of renal function.

Authors: G R Matzke; R W McGory; C E Halstenson; W F Keane
Journal: Antimicrob Agents Chemother Date: 1984-04 Impact factor: 5.191

7. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Authors: T L Smith; M L Pearson; K R Wilcox; C Cruz; M V Lancaster; B Robinson-Dunn; F C Tenover; M J Zervos; J D Band; E White; W R Jarvis
Journal: N Engl J Med Date: 1999-02-18 Impact factor: 91.245

8. Vancomycin dosing in high flux hemodialysis: a limited-sampling algorithm.

Authors: Amy Barton Pai; Manjunath P Pai
Journal: Am J Health Syst Pharm Date: 2004-09-01 Impact factor: 2.637

9. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.

Authors: George Sakoulas; Howard S Gold; Robert A Cohen; Lata Venkataraman; Robert C Moellering; George M Eliopoulos
Journal: J Antimicrob Chemother Date: 2006-02-07 Impact factor: 5.790

10. Treatment guidelines for dialysis catheter-related bacteremia: an update.

Authors: Michael Allon
Journal: Am J Kidney Dis Date: 2009-07 Impact factor: 8.860

10 in total

4 in total

Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.